vs
Side-by-side financial comparison of Bluerock Homes Trust, Inc. (BHM) and SCYNEXIS INC (SCYX). Click either name above to swap in a different company.
Bluerock Homes Trust, Inc. is the larger business by last-quarter revenue ($18.9M vs $18.6M, roughly 1.0× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs -50.1%, a 115.9% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs 35.9%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs 30.1%).
Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
BHM vs SCYX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $18.6M |
| Net Profit | $-9.5M | $12.3M |
| Gross Margin | — | — |
| Operating Margin | -48.8% | 56.3% |
| Net Margin | -50.1% | 65.7% |
| Revenue YoY | 35.9% | 1808.5% |
| Net Profit YoY | -29.9% | 376.5% |
| EPS (diluted) | $-0.75 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $18.6M | ||
| Q3 25 | $16.6M | $334.0K | ||
| Q2 25 | $16.8M | $1.4M | ||
| Q1 25 | $16.4M | $257.0K | ||
| Q4 24 | $13.9M | $977.0K | ||
| Q3 24 | $12.7M | $660.0K | ||
| Q2 24 | $12.5M | $736.0K | ||
| Q1 24 | $11.2M | $1.4M |
| Q4 25 | $-9.5M | $12.3M | ||
| Q3 25 | $-10.0M | $-8.6M | ||
| Q2 25 | $-5.8M | $-6.9M | ||
| Q1 25 | $-7.3M | $-5.4M | ||
| Q4 24 | $-7.3M | — | ||
| Q3 24 | $3.5M | $-2.8M | ||
| Q2 24 | $-5.2M | $-14.5M | ||
| Q1 24 | $-3.2M | $411.0K |
| Q4 25 | -48.8% | 56.3% | ||
| Q3 25 | -57.6% | -2516.5% | ||
| Q2 25 | -30.9% | -701.0% | ||
| Q1 25 | -42.6% | -3350.2% | ||
| Q4 24 | -52.8% | — | ||
| Q3 24 | 27.9% | -1563.6% | ||
| Q2 24 | -41.3% | -1255.0% | ||
| Q1 24 | -28.4% | -692.5% |
| Q4 25 | -50.1% | 65.7% | ||
| Q3 25 | -60.0% | -2572.2% | ||
| Q2 25 | -34.7% | -504.8% | ||
| Q1 25 | -44.7% | -2097.7% | ||
| Q4 24 | -52.8% | — | ||
| Q3 24 | 27.9% | -425.5% | ||
| Q2 24 | -41.3% | -1964.4% | ||
| Q1 24 | -28.4% | 29.9% |
| Q4 25 | $-0.75 | $0.25 | ||
| Q3 25 | $-0.94 | $-0.17 | ||
| Q2 25 | $-0.66 | $-0.14 | ||
| Q1 25 | $-0.67 | $-0.11 | ||
| Q4 24 | $-0.65 | — | ||
| Q3 24 | $0.24 | $-0.06 | ||
| Q2 24 | $-0.42 | $-0.30 | ||
| Q1 24 | $-0.27 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.6M | $40.0M |
| Total DebtLower is stronger | $428.4M | — |
| Stockholders' EquityBook value | $128.7M | $49.4M |
| Total Assets | $1.2B | $59.0M |
| Debt / EquityLower = less leverage | 3.33× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $169.6M | $40.0M | ||
| Q3 25 | $2.1M | $37.9M | ||
| Q2 25 | $4.2M | $44.8M | ||
| Q1 25 | $3.0M | $40.6M | ||
| Q4 24 | $115.2M | $59.3M | ||
| Q3 24 | $155.1M | $68.8M | ||
| Q2 24 | $116.0M | $73.0M | ||
| Q1 24 | $92.3M | $80.2M |
| Q4 25 | $428.4M | — | ||
| Q3 25 | $415.9M | — | ||
| Q2 25 | $338.6M | — | ||
| Q1 25 | $336.5M | — | ||
| Q4 24 | $373.8M | — | ||
| Q3 24 | $122.5M | — | ||
| Q2 24 | $119.7M | — | ||
| Q1 24 | $120.2M | — |
| Q4 25 | $128.7M | $49.4M | ||
| Q3 25 | $131.7M | $36.4M | ||
| Q2 25 | $135.3M | $44.5M | ||
| Q1 25 | $137.1M | $50.5M | ||
| Q4 24 | $139.1M | $55.1M | ||
| Q3 24 | $142.9M | $58.5M | ||
| Q2 24 | $142.5M | $60.4M | ||
| Q1 24 | $144.5M | $74.1M |
| Q4 25 | $1.2B | $59.0M | ||
| Q3 25 | $222.1M | $51.1M | ||
| Q2 25 | $220.3M | $60.7M | ||
| Q1 25 | $186.2M | $67.9M | ||
| Q4 24 | $967.0M | $90.6M | ||
| Q3 24 | $800.8M | $99.0M | ||
| Q2 24 | $756.2M | $107.8M | ||
| Q1 24 | $727.4M | $118.3M |
| Q4 25 | 3.33× | — | ||
| Q3 25 | 3.16× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 2.69× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.83× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.8M | $18.4M |
| Free Cash FlowOCF − Capex | $10.4M | — |
| FCF MarginFCF / Revenue | 55.0% | — |
| Capex IntensityCapex / Revenue | 91.8% | — |
| Cash ConversionOCF / Net Profit | — | 1.50× |
| TTM Free Cash FlowTrailing 4 quarters | $25.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.8M | $18.4M | ||
| Q3 25 | $13.4M | $-8.7M | ||
| Q2 25 | $13.9M | $-7.5M | ||
| Q1 25 | $951.0K | $-7.5M | ||
| Q4 24 | $9.1M | $-24.0M | ||
| Q3 24 | $1.7M | $765.0K | ||
| Q2 24 | $1.3M | $-10.9M | ||
| Q1 24 | $1.1M | $-4.0M |
| Q4 25 | $10.4M | — | ||
| Q3 25 | $8.7M | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $-2.9M | — | ||
| Q4 24 | $-253.0K | — | ||
| Q3 24 | $-601.0K | — | ||
| Q2 24 | $-654.0K | — | ||
| Q1 24 | $-630.0K | — |
| Q4 25 | 55.0% | — | ||
| Q3 25 | 52.4% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | -17.6% | — | ||
| Q4 24 | -1.8% | — | ||
| Q3 24 | -4.7% | — | ||
| Q2 24 | -5.2% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 91.8% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 66.9% | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 15.5% | — |
| Q4 25 | — | 1.50× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -9.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
